Clinical Trial Update: Evolution of the Therapeutic Care in Lung Cancer in France Since 2015 (ESME LC)

View source ↗

Summary

An ongoing observational program (ESME LC) assessing changes in therapeutic care for lung cancer in France since 2015. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: UNICANCER | Conditions: Lung Cancer | Status: RECRUITING